Shareholding disclosure

JPMorgan Chase & Co

Declared position

6.927%

Threshold

Crossed upwards

Timeline

Published

02.02.2022

Transaction

27.01.2022

Voting rights breakdown

Voting rights acquired6.927%

Voting rights sold5.971%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAM2100024

Beneficial owner

JPMorgan Chase & Co

Declared address

JPMorgan Chase & Co., New York

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

JPMorgan Chase & Co

Vifor Pharma AG02.02.2022TAM2100024

Disclosure summary

JPMorgan Chase & Co disclosed a holding in Vifor Pharma AG on the acquisition side, published by SIX Exchange Regulation on 02.02.2022, at 6.927% of voting rights. Notice category: Single shareholder.

Disclosed position

6.927%

Voting rights acquired

Voting rights acquired6.927%

Voting rights sold5.971%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

JPMorgan Chase & Co disclosed a holding in Vifor Pharma AG, published on 02.02.2022.

Publication date02.02.2022

Transaction date27.01.2022

Issuing companyVifor Pharma AG

Beneficial ownerJPMorgan Chase & Co

Declared addressJPMorgan Chase & Co., New York

CategorySingle shareholder

Voting rights acquired6.927%

Voting rights sold5.971%

Below threshold0%

ExchangeXSWX

Notification IDTAM2100024

Source: SIX Exchange Regulation · Publication date: 02.02.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open